A. Paré, Les oeuvres d'Ambroise Paré, 1664.

A. Denmark, «An exampleof Symptoms resembling Tic Douloureux, produced by a wound in the radial nerve,» The medical and physical journal, vol.31, p.1814

S. W. Mitchell, G. R. Morehouse, and W. W. Keen, Gunshot wounds and other injuries of nerves, 1864.

S. W. Mitchell, Injuries of nerves and their consequences, Philadelphie: J.B. Lippincott & Co, 1872.

G. Iolascon, A. De-sire, and A. Moretti, «Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues,» Clinical Cases in Mineral and Bone Metabolism, vol.12, pp.4-10, 2015.

R. Leriche, «De la causalgie envisagée comme une névrite du sympathique et de son traitement par la dénudation et l'excision des plexus nerveux péri-artériels,» La presse médicale, vol.23, pp.178-180, 1916.

P. Sandroni, L. M. Benrud-larson, and R. L. Mcclelland, «Complex regional pain syndrome type I: incidence and prevalence in Olmsted country, a population-based study, » Pain, vol.103, pp.199-207, 2003.

M. De-mos, A. G. De-bruijn, and F. J. Huygen, «The incidence of complex regional pain syndrome: a population-based study, » Pain, vol.129, pp.12-20, 2007.

Y. S. Choi, M. G. Lee, and H. M. Lee, «Epidemiology of complex regional pain syndrome: a retrospective chart review of 150 Korean patients, Journal of Korean Medical Science, vol.23, pp.772-775, 2008.

P. H. Veldman, H. M. Reynen, and I. E. Arntz, «Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients, » Lancet, vol.342, p.114, 1993.

F. Birklein, «Complex regional pain syndrome, Journal of Neurology, vol.252, pp.131-138, 2005.

E. K. Krumova, J. Frettlöh, and S. Klauenberg, «Long-term skin temperature measurements-a practical diagnostic tool in complex regional pain syndrome, » Pain, vol.140, pp.8-22, 2008.

R. J. Schwartzman, K. L. Erwin, and G. M. Alexander, «The natural history of complex regional pain syndrome, vol.25, pp.273-280, 2009.

J. J. Van-hilten, Pain Medicine, vol.11, pp.1274-1277, 2010.

M. A. Van-rijn, J. Marinus, and H. Putter, «Onset and progression of dystonia in complex regional pain syndrome, » Pain, vol.130, pp.287-293, 2007.

J. Gierthmühlen, A. Binder, and R. Baron, «Mechanism-based treatment in complex regional pain syndromes, Nature Reviews Neurology, vol.10, pp.518-528, 2014.

R. N. Harden and S. P. Bruehl, «Diagnosis of complex regional pain syndrome: signs, symptoms, and new empirically derived diagnostic criteria, Clinical Journal of Pain, vol.22, pp.415-419, 2006.

H. Merskey, N. Bogduk, and R. G. Addison, Classification of chronic pain, descriptions of chronic pain syndromes and definitions of pain terms, 1994.

M. F. Reinders, J. H. Geertzen, and P. U. Dijkstra, «Complex regional pain syndrome type I: use of the International Association for the Study of Pain diagnostic criteria defined in 1994, The Clinical Journal of Pain, vol.18, pp.207-2015, 2002.

R. N. Harden, S. Bruehl, and B. S. Galer, «Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?, » Pain, vol.83, p.115, 1999.

S. Bruehl, R. N. Harden, and B. S. Galer, «External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain, » Pain, vol.81, pp.147-154, 1999.

C. Spicher, J. P. Estebe, and E. Létourneau, «Critères diagnostiques du syndrome douloureux régional complexe (SDRC),» Douleur et analgésie, vol.27, pp.62-64, 2014.

R. N. Harden, S. Bruehl, and R. S. Perez, «Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome, » Pain, vol.150, pp.268-274, 2010.

B. S. Galer, S. Bruehl, and R. N. Harden, «IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain, The Clinical Journal of Pain, vol.14, pp.48-54, 1998.

P. Lafforgue, «Les algodystrophies: aspects clinques et diagnostiques,» La lettre du rhumatologue, vol.262, pp.29-36, 2000.

M. Schürmann, J. Zaspel, and P. Löhr, «Imaging in early posttraumatic complex regional pain syndrome: a comparison of diagnostic methods, The Clinical Journal of Pain, vol.23, pp.449-457, 2007.

H. K. Watson and L. Carlson, «Treatment of reflex sympathetic dystrophy of the hand with an active "stress loading" program, The Journal of Hand Surgery, vol.12, pp.779-785, 1987.

L. Rome, «The place of occupational therapy in rehabilitation strategies of complex regional pain syndrome: Comparative study of 60 cases, » Hand Surgery and Rehabilitation, vol.35, pp.355-362, 2016.

E. Dodane, L. Christophe, and Y. Rossetti, «Altération des référentiels spatiaux dans le SDRC: nouveaux concepts et perspectives thérapeutiques,» Kinésithérapie scientifique, vol.552, p.116, 2014.

R. H. Rho, R. P. Brewer, and T. J. Lamer, Mayo Clinic Proceedings, vol.77, pp.174-180, 2002.

D. Celik and M. Demirhan, «Physical therapy and rehabilitation of complex regional pain syndrome in shoulder prosthesis, » The Korean Journal of Pain, vol.23, pp.258-261, 2010.

R. N. Harden, M. Swan, and A. King, «Treatment of complex regional pain syndrome: functional restoration, The Clinical Journal of Pain, vol.22, pp.420-424, 2006.

P. Codine, I. Laffont, and J. Froger, Imagerie mentale thérapie en miroir: applications en rééducation, Montpellier: Sauramps médical, 2012.

G. L. Moseley, Neurology, vol.67, pp.2129-2134, 2006.

R. N. Harden, A. L. Oaklander, and A. W. Burton, «Complex regional pain syndrome: practical diagnostic and treatment guidelines, Pain Medicine, vol.14, pp.180-229, 2013.

K. Christensen, E. M. Jensen, and I. Noer, «The reflex dystrophy syndrome response to treatment with systemic corticosteroids, Acta Chirurgica Scandinavica, vol.148, pp.653-655, 1982.

D. F. Braus, J. K. Krauss, and J. Strobel, «The shoulder-hand syndrome after stroke: a prospective clinical trial, Annals of Neurology, vol.36, pp.728-733, 1994.

J. Kalita, A. Vajpayee, and U. K. Misra, «Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial, » QJM, vol.99, pp.89-95, 2006.

A. K. Tan, I. Duman, and M. A. Taskaynatan, «The effect of gabapentin in earlier stage of reflex sympathetic dystrophy, Clinical Rheumatology, vol.26, pp.561-565, 2007.

A. C. Van-de-vusse, A. H. Kessels, and W. E. Weber, BMC Neurology, vol.29, pp.4-13, 2004.

H. Harke, P. Gretenkort, and H. U. Ladleif, «The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study, Anesthesia & Analgesia, vol.92, pp.488-495, 2001.

V. S. Pereira and V. A. Hiroaki-sato, «A brief history of antidepressant drug development: from tricyclics to beyond ketamine, » Acta Neuropsychiatrica, vol.1, pp.1-16, 2018.

E. P. Baltenberger, W. M. Buterbaugh, and B. Shane-martin, «Review of antidepressants in the treatment of neuropathic pain, Mental Health Clinician, vol.5, pp.123-133, 2015.

Y. Sudoh, E. E. Cahoon, and P. Gerner, «Tricyclic antidepressants as long-acting local anesthetics, » Pain, vol.103, pp.49-55, 2003.

S. H. Sindrup, F. W. Bach, and C. Madsen, «Venlafaxine versus imipramine in painful polyneuropathy: a randomized, vol.60, pp.1284-1289, 2003.

J. C. Stevenson, I. M. Evans, and . Therapeutic-use-of-calcitonin, » Drugs, vol.21, pp.257-272, 1981.

Y. Landry and J. P. Gies, Pharmacologie-3e édition: Des cibles à la thérapeutique, DUNOD, 2014.

D. R. Bickerstaff and J. A. , Kanis, «The use of nasal calcitonin in the treatment of posttraumatic algodystrophy, » British Journal of Rheumatology, vol.30, pp.291-294, 1991.

C. Gobelet, M. Waldburger, and J. L. Meier, «The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy, » Pain, vol.48, pp.171-175, 1992.

F. Sahin, F. Yilmaz, and N. Kotevoglu, «Efficacy of salmon calcitonin in complex 118 regional pain syndrome (type 1) in addition to physical therapy, Clinical Rheumatology, vol.25, pp.143-148, 2006.

J. Zhao, Y. Wang, and D. Wang, «The effect of Ketamine infusion in the treatment of complex regional pain syndrome: a systemic review and Meta-analysis, » Current Pain and Headache Reports, vol.22, p.12, 2018.

D. Q. Tran, S. Duong, and P. Bertini, «Treatment of complex regional pain syndrome: a review of the evidence, Canadian Journal of Anesthesia, vol.57, pp.149-166, 2010.

C. Asher and T. , Furnish, «Lenalidomide and thalidomide in the treatment of chronic pain, Expert Opinion on Drug Safety, vol.12, pp.367-374, 2013.

S. Kharkar, P. Ambady, and Y. Venkatesh, «Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review, » Pain Physician, vol.14, pp.419-424, 2011.

C. Perruchoud, E. Albrecht, and V. Moret, Manuel pratique d'algologie: Prise en charge de la douleur chronique, 2017.

D. Le-bars, J. C. Willer, . De-la, and . Douleur, EMC Anesthésie-Réanimation, vol.1, pp.227-266, 2004.

F. Guirimand, . De-la, and . Douleur, données récentes,» Néphrologie, vol.24, pp.401-407, 2003.

P. Beaulieu, , 2005.

J. K. Cheng and R. R. Ji, «Intracellular signaling in primary sensory neurons and persistent pain, » Neurochemical Research, vol.33, pp.1970-1978, 2008.

D. Le-bars and F. Adam, «Nocicepteurs et médiateurs dans la douleur aiguë inflammatoire,» Annales Francaises d'Anesthésie et de Réanimation, vol.21, p.119, 2002.

A. Dray, British Journal of Anesthesia, vol.75, pp.125-131, 1995.

G. Bhave and R. W. Gereau, «Posttranslational mechanisms of peripheral sensitization, Developmental Neurobiology, vol.61, pp.88-106, 2004.
DOI : 10.1002/neu.20083

A. Kawabata, «Prostaglandin E2 and pain-an update, » Biological and Pharmaceutical Bulletin, vol.34, pp.1170-1173, 2011.
DOI : 10.1248/bpb.34.1170

URL : https://www.jstage.jst.go.jp/article/bpb/34/8/34_8_1170/_pdf

V. Kumar and B. A. , «NGF-the TrkA to successful pain treatment, Journal of Pain Research, vol.2012, issue.5, pp.279-287, 2012.
DOI : 10.2147/jpr.s33408

URL : https://doi.org/10.2147/jpr.s33408

J. K. Bonnington and P. A. Mcnaughton, «Signalling pathways involved in the sensitistion of mouse nociceptive neurones by nerve growth factor, The Journal of Physiology, vol.551, pp.433-446, 2003.

S. Pezet, Biologie Aujourd'hui, vol.208, pp.21-29, 2014.

C. J. Woolf, «Central sensitization: Implications for the diagnosis and treatment of pain, » Pain, vol.152, pp.2-15, 2011.

A. Latremoliere and C. J. Woolf, «Central sensitization: a generator of pain hypersensitivity by central neural plasticity, Journal of pain, vol.10, pp.895-926, 2009.
DOI : 10.1016/j.jpain.2009.06.012

URL : http://europepmc.org/articles/pmc2750819?pdf=render

R. Fagard, C. Benes, and G. Allée, «Protéine-tyrosine kinases de la famille Src dans le système nerveux central, » Médecine/Sciences, vol.13, pp.1106-1112, 1997.
DOI : 10.4267/10608/518

B. S. Chen and K. W. Roche, «Regulation of NMDA receptors by phosphorylation, » Neuropharmacology, vol.53, pp.362-368, 2007.

W. Jänig, R. Schaumann, and W. Vogt, SDRC Syndrome douloureux régional complexe, 2013.

R. Baron and S. N. Raja, «Role of adrenergic transmitters and receptors in nerve and tissue injury related pain,» Mechanisms and Mediators of Neuropathic Pain, pp.153-120

W. Jänig and R. Baron, «Complex regional pain syndrome: mystery explained, The Lancet Neurology, vol.2, pp.687-697, 2003.

C. Maihöfner, H. O. Handwerker, and B. Neundörfer, «Patterns of cortical reorganization in complex regional pain syndrome, » Neurology, vol.23, pp.1707-1715, 2003.

C. Maihöfner, H. O. Handwerker, and B. Neundörfer, «Cortical reorganization during recovery from complex regional pain syndrome, » Neurology, vol.63, pp.693-701, 2004.

J. Marinus, G. L. Moseley, and F. Birklein, «Clinical features and pathophysiology of complex regional pain syndrome, » Neurology, vol.63, pp.693-701, 2004.
DOI : 10.1016/s1474-4422(11)70106-5

URL : http://europepmc.org/articles/pmc5511749?pdf=render

P. Y. Geha, M. N. Baliki, and R. N. Harden, «The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions, » Neuron, vol.60, pp.570-581, 2008.

S. Bruehl, «An update on the pathophysiology of complex regional pain syndrome, » Anesthesiology, vol.113, pp.713-725, 2010.

H. Fleisch, Breast Cancer Research, vol.4, pp.30-34, 2002.

S. Cakarer, F. Selvi, C. Keskin, and . Bone, Orthopedic Surgery, p.8, 2012.

R. G. , «Bisphosphonates: mode of action and pharmacology, Pediatrics, vol.119, pp.150-162, 2007.

M. D. Francis and D. J. Valent, «Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases, Journal of Musculoskeletal and Neuronal Interactions, vol.7, p.121, 2007.

M. J. Rogers, S. Gordon, and H. L. Benford, «Cellular and molecular mechanisms of action of bisphosphonates, » Cancer, vol.88, pp.2961-2978, 2000.

M. T. Drake, «Bisphosphonates: Mechanism of action and role in clinical practice, Mayo Clinic Proceedings, vol.83, pp.1032-1045, 2008.

R. G. Russell, «Bisphosphonates. From bench to bedside,» The New York Academy of Sciences, vol.1068, pp.367-401, 2006.

D. E. Hughes, B. R. Macdonald, and R. G. Russell, «Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow, Journal of Clinical Investigation, vol.83, pp.1930-1935, 1989.

P. M. Boonekamp, L. J. Van-der-wee-pals, and C. W. Thesing, «Two modes of action of bisphosphonates on octeoclastic resorption of mineralized matrix, Bone and Mineral, vol.1, pp.27-39, 1986.

C. W. Löwik, G. Van-der-pluijm, and L. J. Van-der-wee-pals, «Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate, Journal of Bone and Mineral Research, vol.3, pp.185-192, 1988.

Y. Azuma, H. Sato, and Y. Oue, «Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models, » Bone, vol.16, pp.235-245, 1995.

M. Sato and W. Grasser, «Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy, vol.5, pp.31-40, 1990.

M. Nishikawa, T. Akatsu, and Y. Katayama, «Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures, » Bone, vol.18, pp.9-14, 1996.

M. Ito, M. Chokki, and Y. Ogino, , p.122

, Calcified Tissue International, vol.63, pp.143-147, 1998.

V. Breuil, F. Cosman, and L. Stein, «Human osteoclast formation and activity in vitro: effects of alendronate, Journal of Bone and Mineral Research, vol.13, pp.1721-1729, 1998.

D. E. Hughes, K. R. Wright, and H. L. Uy, «Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo, Journal of Bone and Mineral Research, vol.10, pp.1478-1487, 1995.

K. S. Selander, J. Mönkkönen, and E. K. Karhukorpi, «Characteristics of clodronateinduced apoptosis in osteoclasts and macrophages, Molecular Pharmacology, vol.50, pp.1127-1138, 1996.

M. J. Rogers, J. F. Apperley, and C. M. Shipman, «Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity, » British Journal of Haematology, vol.98, pp.665-672, 1997.

A. Carano, S. L. Teitelbaum, and J. D. Konsek, «Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro, The Journal of Clincal Investigation, vol.85, pp.456-461, 1990.

W. Grasser, N. Endo, and M. Sato, «Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure, The Journal of Clinical Investigation, vol.88, pp.2095-2105, 1991.

N. Takahashi, T. Sasaki, and H. Murakami, «A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders, Bone, vol.17, pp.137-144, 1995.

A. Schmidt, S. J. Rutledge, and N. Endo, «Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate, Proceedings of the National Academy of Sciences of the United States of America, vol.93, pp.3068-3073, 1996.

H. Murakami, N. Takahashi, and S. Tanaka, «Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts, Bone, vol.20, pp.399-404, 1997.

M. J. Rogers, X. Xiong, and R. J. Brown, «Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae, Molecular Pharmacology, vol.47, pp.398-402, 1995.

M. J. Rogers, R. G. Russell, and G. M. Blackburn, «Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum, » Biochemical and Biophysical Research Communications, vol.189, pp.414-423, 1992.

J. C. Frith, J. Mönkkönen, and S. Auriola, «The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis, Arthritis and Rheumatism, vol.44, pp.2201-2210, 2001.

M. J. Rogers, J. C. Crockett, and F. P. Coxon, «Biochemical and molecular mechanisms of action of bisphosphonates, » Bone, vol.49, pp.34-41, 2011.

M. Thurnher, O. Nussbaumer, and G. Gruenbacher, «Novel aspects of mevalonate pathway inhibitors as antitumor agents, Clinical Cancer Research, vol.18, pp.3524-3531, 2012.

J. F. Pouliot and R. Béliveau, «Modifiactions post-traductionnelles des protéines par les lipides,» Médicine/Sciences, vol.10, pp.65-73, 1994.
DOI : 10.4267/10608/2481

URL : http://www.ipubli.inserm.fr/bitstream/10608/2481/1/MS_1994_1_65.pdf

L. Gong, R. B. Altman, and T. E. Klein, Pharmacogenetics and Genomics, vol.21, pp.50-53, 2011.

«. Protein and . Bank,

«. Protein and . Bank,

. Available,

K. L. Kavanagh, K. Guo, and J. E. Dunford, «The molecular mechanism of nitrogencontaining bisphosphonates as antiosteoporosis drugs, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.7829-7834, 2006.

C. Itzstein, F. P. Coxon, and M. J. Rogers, «The regulation of osteoclast function and bone resorption by small GTPases, Small GTPases, vol.2, pp.117-130, 2011.

G. Tramu and I. Kramer, «Introduction à la signalisation cellulaire, 2013.

. Available,

A. V. Smrcka, «G protein Beta-Gamma subunits: central mediators of G proteincoupled receptor signaling, » Cellular and Molecular Life Sciences, vol.65, pp.2191-2214, 2008.

R. R. Ji, R. W. Gereau, and M. Malcangio, Brain Research Reviews, vol.60, pp.135-148, 2009.

K. A. Kennel and M. T. Drake, «Adverse effects of bisphosphonates: implications for osteoporosis management, Mayo Clinic Proceedings, vol.84, pp.632-637, 2009.

S. Greenspan, R. Tonino, and M. Smith, «Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study, vol.77, pp.1044-1052, 2002.

S. T. Harris, N. B. Watts, and H. K. Genant, «Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group, JAMA, vol.282, p.125, 1999.

C. H. Chesnut, A. Skag, and C. Christiansen, «Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis, Journal of Bone and Mineral Research, vol.19, pp.1241-1249, 2004.

D. M. Black, P. D. Delmas, and R. Eastell, «Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis, The New England Journal of Medicine, vol.356, pp.1809-1822, 2007.

P. D. Delmas, S. Adami, and C. Strugala, «Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study, Arthritis and Rheumatism, vol.54, pp.1838-1846, 2006.

G. Dicuonzo, B. Vincenzi, and D. Santini, «Fever after zoledronic acid administrationis due to increase in TNF-alpha and IL-6, Journal of Interferon & Cytokine Research, vol.23, pp.649-654, 2003.

A. Khan, «Bisphosphonate-associated osteonecrosis of the jaw, Canadian Family Physician, vol.54, pp.1019-1021, 2008.

A. Sharma, A. J. Einstein, and A. Vallakati, «Risk of atrial fibrillation with use of oral and intravenous bisphosphonates, The American Journal of Cardiology, vol.113, pp.1815-1821, 2014.

Y. Saita, M. Ishijima, and K. Kaneko, «Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications,» Therapeutic Advances in Chronic disease, vol.6, pp.185-193, 2015.

J. H. Lin, «Bisphosphonates: A review of their pharmacokinetic properties,» Bone, vol.18, pp.75-85, 1996.

S. Faure, Actualités Pharmaceutiques, vol.53, p.126, 2014.

A. Beerthuizen, D. L. Stronks, and A. Van't-spijker, «Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture, » Pain, vol.153, pp.1187-1192, 2012.

M. De-mos, F. J. Huygen, and M. Van-der-hoeven-borgman, «Outcome of the complex regional pain syndrome, The Clinical Journal of Pain, vol.25, pp.590-597, 2009.

G. Allen, B. S. Galer, and L. Schwartz, «Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients, » Pain, vol.80, pp.539-544, 1999.

J. N. Robinson, J. Sandom, and P. T. Chapman, «Efficacy of pamidronate in complex regional pain syndrome type I, » Pain Medicine, vol.5, pp.276-280, 2004.

D. H. Manicourt, J. P. Brasseur, and Y. Boutsen, «Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity, Arthritis and Rheumatism, vol.50, pp.3690-3697, 2004.

I. Kubalek, O. Fain, and J. Paries, «Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases, » Rheumatology, vol.40, pp.1394-1397, 2001.

M. Varenna, S. Adami, and M. Rossini, «Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study, » Rheumatology, vol.52, pp.534-542, 2013.

J. F. Maillefert, C. Chatard, and S. Owen, «Treatment of refractory reflex sympathetic dystrophy with pamidronate,» Annals of the rheumatic diseases, vol.54, p.687, 1995.

C. Guy-coichard and F. Boureau, La Revue de Medecine Interne, vol.26, pp.226-232, 2005.